PROVIDA PENSION FUND ADMINISTRATOR Q2 2023 Portfolio
Sym
Weight
Trade Impact
Company
Class
Share Change
Activity
Value Change $
Value $
* Price $
Shares
Principal
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
This filing lists securities holdings reported on the form 13F filed on 10 Aug 2023 pursuant to a request for confidential treatment and for which confidential treatment expired on 01 Dec 2023.
Person Signing this Report on Behalf of Reporting Manager:
Name
Title
City, State
Date
Santiago Donoso
CEO Provida
Santiago, Chile
09 Feb 2024
This filing publicly lists two holdings that were initially reported on the 13F-CTR/A filed on 10/26/23 and for which confidential treatment expired on 12/1/23. Please note that this 13F Holdings Report filer is affiliated with MetLife Investment Management, LLC and Metropolitan Life Insurance Company who are also filing 13F Holdings Reports. Each entity is filing its own 13F Holdings Report because each entity has investment discretion over certain 13(f) securities reported. All three 13F Holdings Report filers are under common control of their ultimate parent, MetLife, Inc., who is filing a 13F Combination Report.
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.